Shozo Fukuda is a seasoned pharmaceutical industry leader currently spearheading global business development and international sales for NGK’s Crystal Polymorphism Screening Service.

With over 20 years of expertise in the pharmaceutical sector, Shozo brings a wealth of experience in sales, leadership, and strategic execution to his current role. He played a pivotal part in the initial launch of NGK’s screening service, where he was instrumental in both the high-level strategic planning and the hands-on expansion of the business. After successfully driving domestic visibility and adoption within the Japanese market, he transitioned to his current focus on supporting global initiatives. His deep industry background allows him to bridge technical service offerings with the complex needs of international pharmaceutical partners.